Literature DB >> 11875611

Outcome of orthotopic liver transplantation in autoimmune hepatitis according to subtypes.

Pierre Cattan1, Thierry Berney, Filomena Conti, Yvon Calmus, J C Homberg, Didier Houssin, Olivier Soubrane.   

Abstract

The relevance of autoimmune hepatitis (AIH) classification for clinical purposes is controversial. We analyzed the outcome after orthotopic liver transplantation (OLT) of nine type I and seven type II AIH patients. Type II patients had a significantly higher incidence of cirrhosis at the time of diagnosis, more resistance to steroid therapy, and a higher Child-Pugh score at the time of OLT. OLT was performed in emergency in three type II patients and electively in all type I patients. Four type II and one type I patients died in the postoperative period. There was no difference regarding the incidence of post-OLT infection and rejection between the two types. No recurrence of AIH was observed. The 6-year actuarial survival rates for type I and type II patients were 76% and 43%, respectively. Type II AIH patients who have a poor response to medical therapy should be considered for OLT with a shortened delay.

Entities:  

Mesh:

Year:  2002        PMID: 11875611     DOI: 10.1007/s00147-001-0376-7

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  4 in total

1.  Outcomes in children who underwent transplantation for autoimmune hepatitis.

Authors:  Steven R Martin; Fernando Alvarez; Ravinder Anand; Changhong Song; Wanrong Yin
Journal:  Liver Transpl       Date:  2011-04       Impact factor: 5.799

Review 2.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

Review 3.  Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

4.  Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era.

Authors:  Johannes Klose; Michelle A Klose; Courtney Metz; Frank Lehner; Michael P Manns; Juergen Klempnauer; Nils Hoppe; Harald Schrem; Alexander Kaltenborn
Journal:  Langenbecks Arch Surg       Date:  2014-06-04       Impact factor: 3.445

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.